Attributes | Values |
---|
rdf:type
| |
Description
| - In two tumour models, 3MC-induced MHC class I + sarcoma Mc12 HPV 16 E6/E7 oncogene-induced MHC class I - carcinoma MK16, the effectiveness of combined chemoimmunotherapy with ifosfamide derivative CBM-4A and GM-CSF was investigated. In both types of tumours, the combined chemoimmunotherapy can inhibit tumour progression more effectively than GM-CSF therapy or chemotherapy alone.
- In two tumour models, 3MC-induced MHC class I + sarcoma Mc12 HPV 16 E6/E7 oncogene-induced MHC class I - carcinoma MK16, the effectiveness of combined chemoimmunotherapy with ifosfamide derivative CBM-4A and GM-CSF was investigated. In both types of tumours, the combined chemoimmunotherapy can inhibit tumour progression more effectively than GM-CSF therapy or chemotherapy alone. (en)
|
Title
| - Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.
- Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A. (en)
|
skos:prefLabel
| - Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.
- Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A. (en)
|
skos:notation
| - RIV/68378050:_____/01:23010376!RIV/2003/AV0/A23003/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA301/00/0114), P(GA301/01/0985), P(GA312/99/0542), P(IAA7052002), P(NC5526), P(NC5900), Z(AV0Z5052915)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378050:_____/01:23010376
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - chemoimmunotherapy; - murine; - neoplasms (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...ocetUcastnikuAkce
| |
http://linked.open...nichUcastnikuAkce
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Bieblová, Jana
- Bubeník, Jan
- Indrová, Marie
- Mikyšková, Romana
- Šímová, Jana
- Šmahel, M.
- Jandlová, Táňa
- Pajtasz-Piasecka, E.
- Radzikowski, C.
- Vonka, V.
- Glazman-Kusnierczyk, H.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |